Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate Adds Manufacturing Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Laureate Adds Manufacturing Capacity

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Pharma, Inc. is increasing its manufacturing capacity with the addition of two Single-Use Bioreactors (S.U.B.), a 250L and a 1000L S.U.B.  The S.U.B. is a single-use alternative to stirred tank bioreactors. The S.U.B. consists of a permanent stainless steel outer support container and a Bioprocess Container (BPC), integrated with an existing bioreactor control system. According to the company, this provides a flexible, rapid and economic option to update or increase the bioreactor capacity. The S.U.B. will supplement the company’s current single-use bioreactors, Wave Bioreactors and hollow-fiber systems, as well as the conventional stainless steel stirred-tank bioreactors.
   
“We are excited about adding the S.U.B. to increase our bioreactor capacity. It is a scalable technology that will support the demand from our growing client base and meet their needs and manufacturing objectives,” said Robert J. Broeze, Ph.D., president and chief executive officer of Laureate. “The HyClone S.U.B. provides us with all the advantages of single-use bioprocessing, while maintaining aspect ratios and agitation mechanisms comparable to traditional stainless steel stirred-tank bioreactors.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters